×

Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting: A systematic review

  • Author

    Inch J Watson M Anakwe-Umeh Hazell L on behalf of the Yellow Card Study Collaboration

  • Cite

    Drug Saf. 2012 Oct 1;35(10):807-18

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

  • Author

    Shakir S Marshall V Camm AJ Kannankeril PJ Dalageorgou C Jamshidi Y Bastiaenen R Jeffery S Nolte IM Zheng D Johnson T Ruddy S Talott D Norris KJ Snieder H George AL Munroe PB Roden DM and Behr ER

  • Cite

    Journal of the American College of Cardiology. 2012 Aug 28;60(9):841-50

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes

  • Author

    Shakir S Mackenzie IS MacDonald TM Dryburgh M Mantay BJ McDonnell P and Layton D

  • Cite

    British Journal of Clinical Pharmacology, May 2012; 73(5):801-11

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes Kääb

  • Author

    Shakir S Behr ER Marshall V Camm AJ Ritchie MD Crawford DC Sinner MF Kannankeril PJ Wilde AA Bezzina CR Schulze-Bahr E Zumhagen S Guicheney P Bishopric NH Dalageorgou C Jamshidi Y Myerburg RJ Schott JJ Steinbeck G Norris K Jeffery S George AL Jr Roden DM. Kääb S1 Pfeufer A Beckmann BM Martens E Zhang T Stallmeyer B Denjoy I Bardai A Van Gelder IC Perz S Lichtner P Meitinger T Peters A Wichmann HE Ingram C Bradford Y Carter S

  • Cite

    Circulation: Cardiovascular Genetics. 2012 Feb 1;5(1):91-9

Free to view

Modified Prescription-Event Monitoring Studies: a tool for Pharmacovigilance and Risk Management

  • Author

    Layton D Hazell L and Shakir S

  • Cite

    Drug Safety. 2011 December 1;34(12)

Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data

  • Author

    Osborne V Layton D Gilchrist A & Shakir S

  • Cite

    Drug Safety. 2011 Dec 1;34(12):1177-89

Risk of depressive episodes with rimonabant: a before and after modified prescription-event monitoring study conducted in England

  • Author

    Buggy Y Cornelius V Wilton L and Shakir S

  • Cite

    Drug Safety. 2011 Jun 1;34(6):501-9

Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults

  • Author

    Aurich-Barrera B Wilton L Brown D and Shakir S

  • Cite

    Pharmacoepidemiology and Drug Safety. 2011 Jun;20(6):608-18

New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UK

  • Author

    Lynn E Layton D and Shakir S

  • Cite

    Drug Safety. 2011 Jan 1;34(1):89-91

Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study.

  • Author

    Shakir S. Cornelius V Kasliwal R Wilton L Vlckova V

  • Cite

    J Eval Clin Pract. 2010 Dec;16(6):1124-8

Paediatric postmarketing pharmacovigilance using prescription-event monitoring: a comparison of the adverse event profiles of lamotrigine prescribed in children and adults in England

  • Author

    Aurich-Barrera B Wilton L Brown D and Shakir S

  • Cite

    Drug Safety. 2010 Sep 1;33(9):751-63

Adverse drug reaction reporting in the UK: A retrospective observational comparison of Yellow Card Reports submitted by patients and healthcare professionals

  • Author

    Hannaford P McLernon D Bond C Watson M Lee A Hazell L and Avery A on behalf of the Yellow Card Collaboration

  • Cite

    Drug Safety. 2010 Sep 1;33(9):775-88

Incidence of venous thromboembolism in users of strontium ranelate: an analysis of data from a prescription-event monitoring study in England

  • Author

    Osborne V Layton D Wilton L and Shakir S Perrio M

  • Cite

    Drug Safety. 2010 Jul 1;33(7):579-91

Safety profile of oxcarbazepine: results from a prescription-event monitoring study

  • Author

    Layton D Buggy Y Fogg C and Shakir S

  • Cite

    Epilepsia. 2010 May;51(5):818-29

Drug Utilization of Intrinsa (Testosterone Patch) In England: Interim analysis of a Prescription-Event Monitoring Study to support Risk Management

  • Author

    Osborne V Hazell L Layton D and Shakir S

  • Cite

    Drug Saf. 2010 Mar 1;33(3):213-21

Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality Cornelius

  • Author

    Shakir SA Cornelius VR Perrio MJ Smith LA

  • Cite

    Pharmacoepidemiol Drug Saf. 2009 Dec;18(12)

Strontium ranelate as a cause of acute renal failure and dress syndrome

  • Author

    Buggy Y Iyer D O'Reilly K Searle M

  • Cite

    Nephrology (Carlton). 2009 Sep;14(6):624

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients.

  • Author

    Hazell L Shakir SA. Cornelius V Wilton LV

  • Cite

    BJU Int. 2009 Feb;103(4):506-14

Pattern of drug utilisation for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy

  • Author

    Fogg C Dodoo AN Asiimwe A Nartey ET Kodua A Tenkorang O Ofori-Adjei D

  • Cite

    Malar J. 2009 Jan 5;8:2

Safety Profile of Varenicline as used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

  • Author

    Shakir S Kasliwal R Wilton L

  • Cite

    Drug Safety. 2009;32(6):499-507

Hypoglycaemia with anti-diabetic drugs: Results from Prescription-Event Monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide

  • Author

    Shakir S Cornelius V Kasliwal R Wilton L Vickova V

  • Cite

    Drug Safety. 2009;32(5):409-18

Risk management and outcomes of adverse events to Pioglitazone in Primary Care in the UK; an observational study

  • Author

    Fogg C Shakir SA Kasliwal R

  • Cite

    Drug Safety. 2009;32(3):229-37

Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects

  • Author

    Layton D Cox A

  • Cite

    The Pharmaceutical Journal. January 2009

Use and risk management of Carvedilol for the treatment of heart failure in the community in England: results from a modified prescription-event monitoring study

  • Author

    Shakir SA Aurich-Barrera B Wilton LV

  • Cite

    Drug Safety. 2009;32(1):43-54.

Antipsychotics and stroke: the story to date

  • Author

    Layton D Cox A

  • Cite

    The Pharmaceutical Journal. January 2009